|
Time (UTC -5)*
|
Topic
|
Speaker
|
Affiliation
|
|
8:00 AM
|
Welcome & Introduction
|
Hagop Kantarjian, MD
|
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
|
|
8:10 AM
|
State of the Art & Next Questions: Acute Lymphoblastic Leukemia
|
Elias Jabbour, MD
|
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
|
|
8:35 AM
|
Audience Q & A
|
|
|
|
8:45 AM
|
State of the Art & Next Questions: Acute Myeloid Leukemia
|
Hagop Kantarjian, MD
|
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
|
|
9:10 AM
|
Audience Q & A
|
|
|
|
9:20 AM
|
State of the Art & Next Questions: Cellular Therapy
|
Sergio Giralt, MD
|
Memorial Sloan Kettering Cancer Center, New York, New York, USA
|
|
9:45 AM
|
Audience Q & A
|
|
|
|
9:55 AM
|
State of the Art & Next Questions: Chronic Lymphocytic Leukemia
|
Jennifer R. Brown, MD, PhD
|
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
|
|
10:20 AM
|
Audience Q & A
|
|
|
|
10:30 AM
|
Break
|
|
|
|
10:45 AM
|
State of the Art & Next Questions: Chronic Myeloid Leukemia
|
Jorge Cortes, MD
|
Georgia Cancer Center at Augusta University, Augusta, Georgia, USA
|
|
11:10 AM
|
Audience Q & A
|
|
|
|
11:20 AM
|
State of the Art & Next Questions: Multiple Myeloma
|
Sagar Lonial, MD, FACP
|
Emory University, Atlanta, Georgia, USA
|
|
11:45 AM
|
Audience Q & A
|
|
|
|
11:55 AM
|
State of the Art & Next Questions: Indolent B-Cell Lymphoma
|
Laurie Sehn, MD, MPH
|
BC Cancer Agency and University of British Columbia, Vancouver, Canada
|
|
12:20 PM
|
Audience Q & A
|
|
|
|
12:30 PM
|
State of the Art & Next Questions: T-Cell Lymphoma
|
Barbara Pro, MD
|
Robert H Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA
|
|
12:55 AM
|
Audience Q & A
|
|
|
|
1:05 PM
|
Break
|
|
|
|
1:35 PM
|
State of the Art & Next Questions: Mantle Cell Lymphoma
|
Brad S. Kahl, MD
|
Washington University Medical School, St. Louis, Missouri, USA
|
|
2:00 PM
|
Audience Q & A
|
|
|
|
2:10 PM
|
State of the Art & Next Questions:Hodgkin Lymphoma
|
Craig H. Moskowitz, MD
|
University of Miami Health System, Miami, Florida, USA
|
|
2:35 PM
|
Audience Q & A
|
|
|
|
2:45 PM
|
State of the Art & Next Questions: Aggressive B-Cell Lymphoma
|
Grzegorz S. Nowakowski, MD
|
Mayo Clinic Rochester, Rochester, Minnesota, USA
|
|
3:10 PM
|
Audience Q & A
|
|
|
|
3:20 PM
|
State of the Art & Next Questions: Myelodysplastic Syndromes
|
Guillermo Garcia-Manero, MD
|
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
|
|
3:45 PM
|
Audience Q & A
|
|
|
|
3:55 PM
|
State of the Art & Next Questions: Myeloproliferative Neoplasms
|
Srdan Verstovsek, MD, PhD
|
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
|
|
4:20 PM
|
Audience Q & A
|
|
|
|
4:30 PM
|
Closing Remarks
|
Jennifer R. Brown, MD, PhD
|
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
|
|
4:35 PM
|
Adjourn
|
|
|
